4-halogenerte 17-metylensteroider, fremgangsmåte for fremstilling derav ogfarmasöytiske preparater som inneholder disse forbindelsene

摘要

The inventive compounds have an active profile with a hybrid character of such that they act as inhibitors of the 5 alpha -reductase and, at the same time, as gestagens. Said compounds are thus suited for treating medical disorders that, in men and women, are a result of an increased androgen level in certain organs and tissues. The inventive compounds combined with other hormonal substances such as estrogen, testosterone or a potent androgen are suited as contraceptives for women and men.